One Team. No Boundaries.

Part of the pioneering team at GSK who established the field of Targeted Protein Degradation in collaboration with Craig Crews and Alessio Ciulli. Helped to conceive and build biomedical knowledge graphs and data science platforms for drug discovery at Benevolent AI. Delivered multiple drugs to clinical trials.

Specializes in integrating structural biology, molecular dynamics, and machine learning to identify novel pockets, having published several patents, papers, and talks in the field. A leader of multiple tech teams, they have a proven track record of delivering on products, collaborations, and internal projects.